Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms

Frontiers in Neuroscience
Sylvie VancasselNathalie Castanon

Abstract

The prevalence of depressive disorders is growing worldwide, notably due to stagnation in the development of drugs with greater antidepressant efficacy, the continuous large proportion of patients who do not respond to conventional antidepressants, and the increasing rate of chronic medical conditions associated with an increased vulnerability to depressive comorbidities. Accordingly, better knowledge on the pathophysiology of depression and mechanisms underlying depressive comorbidities in chronic medical conditions appears urgently needed, in order to help in the development of targeted therapeutic strategies. In this review, we present evidence pointing to inflammatory processes as key players in the pathophysiology and treatment of depressive symptoms. In particular, we report preclinical and clinical findings showing that inflammation-driven alterations in specific metabolic pathways, namely kynurenine and tetrahydrobiopterin (BH4) pathways, leads to substantial alterations in the metabolism of serotonin, glutamate and dopamine that are likely to contribute to the development of key depressive symptom dimensions. Accordingly, anti-inflammatory interventions targeting kynurenine and BH4 pathways may be effective as novel tr...Continue Reading

References

Jun 1, 1989·Biological Psychiatry·S Knapp, M Irwin
Mar 19, 1983·Lancet·H C CurtiusJ Angst
Jul 21, 1984·Lancet·J A BlairA Coppen
Dec 22, 1984·Lancet·B WoggonA Niederwieser
Feb 1, 1984·Psychiatry Research·D S DuchJ C Garbutt
Oct 1, 1995·Biological Psychiatry·M T Abou-SalehJ A Blair
Jan 1, 1995·Journal of Neural Transmission. General Section·I NagatsuT Nagatsu
Feb 4, 1998·Brain Research·D DassesseA Résibois
Mar 4, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S LanquillonH Vedder
Mar 9, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M KamataT Shimizu
Mar 23, 2000·Progress in Neurobiology·K KoshimuraY Kato
Mar 29, 2001·The New England Journal of Medicine·D L MusselmanA H Miller
Apr 3, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lucile CapuronAndrew H Miller
Apr 17, 2002·Journal of Neural Transmission·U MüllerH Topka
May 11, 2002·Current Drug Metabolism·C MurrD Fuchs
Oct 18, 2003·American Journal of Physiology. Gastrointestinal and Liver Physiology·Hideaki KazumoriYoshikazu Kinoshita
Dec 19, 2003·Experimental Biology and Medicine·Ernst R WernerBernd Mayer
Oct 29, 2004·Cell Biochemistry and Biophysics·Wenjuan ShiGuoyao Wu
Aug 9, 2005·Biological Psychiatry·Dwight L EvansWilliam J Valvo
Dec 1, 2005·Trends in Immunology·Charles L RaisonAndrew H Miller
Dec 20, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·J L K Van HoveP Casaer
Feb 3, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chong-Bin ZhuWilliam A Hewlett
Aug 15, 2006·BJOG : an International Journal of Obstetrics and Gynaecology·R Cancello, K Clément
Aug 26, 2006·Journal of Neural Transmission·H-Q WuR Schwarcz
Jan 24, 2007·Biological Psychiatry·Stefan KloiberSusanne Lucae
Mar 1, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lucile CapuronAndrew H Miller
Nov 17, 2007·Biological Psychiatry·Stéphane PotvinEdouard Kouassi
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Benjamin B GelmanVicki M Soukup

❮ Previous
Next ❯

Citations

Aug 4, 2019·Journal of Neurochemistry·Freek J H SorgdragerPeter P De Deyn
Nov 22, 2019·Nutrition Reviews·Olivia G SwannWendy H Oddy
Nov 28, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·Yu E Shilov, I I Miroshnichenko
Jul 31, 2020·Journal of Neuroimmunology·Marc A RussoPaul J Austin
Jan 3, 2021·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Igor BranchiUNKNOWN European College of Neuropsychopharmacology (ECNP) ImmunoNeuroPsychiatry Thematic Working Group and Marion Leboyer
May 25, 2021·British Journal of Pharmacology·Myrthe MampayGraham K Sheridan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here